Results 1 to 10 of about 74,242 (343)

CDK1 bridges NF-κB and β-catenin signaling in response to H. pylori infection in gastric tumorigenesis

open access: yesCell Reports, 2023
Summary: Infection with Helicobacter pylori (H. pylori) is the main risk factor for gastric cancer, a leading cause of cancer-related death worldwide.
Mohammed Soutto   +2 more
exaly   +4 more sources

Targeting CDK1 in cancer: mechanisms and implications

open access: yesnpj Precision Oncology, 2023
Cyclin dependent kinases (CDKs) are serine/threonine kinases that are proposed as promising candidate targets for cancer treatment. These proteins complexed with cyclins play a critical role in cell cycle progression.
Qiushi Wang, Ann M. Bode, Tianshun Zhang
doaj   +4 more sources

Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors [PDF]

open access: bronzeMedical Oncology, 2022
Cell cycle dysregulation is a characteristic hallmark of malignancies, which results in uncontrolled cell proliferation and eventual tumor formation. Cyclin-dependent kinase 1 (CDK1) is a member of the family of cell cycle regulatory proteins involved in
Shazia Sofi   +6 more
semanticscholar   +4 more sources

Post-translational modification of CDK1–STAT3 signaling by fisetin suppresses pancreatic cancer stem cell properties

open access: yesCell & Bioscience, 2023
Background Pancreatic cancer stem cells (CSCs) promote pancreatic ductal adenocarcinoma (PDAC) tumorigenesis and chemoresistance. Cyclin-dependent kinase 1 (CDK1) plays an important role in tumor initiation in other tumors, but the function of CDK1 in ...
Xiaodong Xu   +9 more
doaj   +2 more sources

Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4‐mediated Ferroptosis in Colorectal Cancer

open access: yesAdvanced Science, 2023
Oxaliplatin is a widely used chemotherapy drug for patients with advanced colorectal cancer (CRC); however, frequent drug resistance limits its therapeutic efficacy in patients.
Weihao Li, Chi Zhou
exaly   +2 more sources

CDK1 serves as a potential prognostic biomarker and target for lung cancer

open access: yesJournal of International Medical Research, 2020
Objective Evidence from cell and mouse models and human tissues suggests that cyclin dependent kinase 1 (CDK1) is involved in lung cancer (LC) tumorigenesis.
Mingyao Li   +4 more
doaj   +2 more sources

Phosphoproteome Remodeling upon CDK1 Inhibition Restricts HSV-1 IE Gene Transcription and Replication [PDF]

open access: yesCells
Cyclin-dependent kinase 1 (CDK1) regulates multiple cellular processes that HSV-1 can exploit to promote its own replication, particularly during the early steps of lytic infection.
Maxim S. Rodzkin   +2 more
doaj   +2 more sources

USP14 regulates cell cycle progression through deubiquitinating CDK1 in breast cancer

open access: yesActa Biochimica et Biophysica Sinica, 2022
Abnormal proliferation and cell cycle perturbation are the main hallmarks of breast cancer. Cyclin-dependent kinase 1 (CDK1) is one of the key kinases for cell transition from the G2 phase to M phase during the cell cycle progression.
Liu Yuhan   +6 more
doaj   +2 more sources

Differences in the Conformational Energy Landscape of CDK1 and CDK2 Suggest a Mechanism for Achieving Selective CDK Inhibition

open access: yesCell Chemical Biology, 2019
Summary Dysregulation of the cell cycle characterizes many cancer subtypes, providing a rationale for developing cyclin-dependent kinase (CDK) inhibitors. Potent CDK2 inhibitors might target certain cancers in which CCNE1 is amplified.
Natalie J Tatum   +2 more
exaly   +2 more sources

The circular RNA circ-Ccnb1 dissociates Ccnb1/Cdk1 complex suppressing cell invasion and tumorigenesis

open access: yesCancer Letters, 2019
Circular RNAs represent a large class of non-coding RNAs that are extensively expressed in mammals. However, the functions of circular RNAs are largely unknown.
Faryal Mehwish Awan, Burton B Yang
exaly   +2 more sources

Home - About - Disclaimer - Privacy